Abstract
Measles virus can cause two acute neurological disorders: acute infectious encephalitis and postinfectious autoimmune encephalitis, each with a risk of about 1 in 1,000 measles cases. Two other rare neurological problems manifest after a latent period: subacute measles encephalitis occurring in immunocompromised individuals, and subacute sclerosing panencephalitis (SSPE) in immunocompetent hosts. SSPE develops 1–10 years after measles infection; it is usually progressive and fatal. Mental and behavioral changes, myoclonia, and ataxia are typical initial manifestations. The diagnosis is based on the demonstration of intrathecal anti-measles virus immunoglobulin G synthesis. Pathological examination of brain biopsy or autopsy material demonstrates inflammation, neuronal loss, gliosis, demyelination, and typically, inclusion bodies containing measles virus antigens or RNA. Treatment with inosiplex and interferons may induce temporary stabilization or remission in about 30–35 % of the cases. Immunization against measles virus and maintenance of immunization rates above 90 % in the population are of extreme importance for the prevention of these debilitating or fatal disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ADEM:
-
Acute disseminated encephalomyelitis
- CSF:
-
Cerebrospinal fluid
- EEG:
-
Electroencephalography
- IL:
-
Interleukin
- MRI:
-
Magnetic resonance imaging
- MV:
-
Measles virus
- SSPE:
-
Subacute sclerosing panencephalitis
References
Adels BR, Gajdusek C, Gibbs CJ Jr, Albrecht P, Rogers NG (1968) Attempts to transmit subacute sclerosing panencephalitis and isolate a measles virus related agent, with a study of the immune response in patients and experimental animals. Neurology 18:30–51
Albertyn C, van der Plas H, Hardie D, Candy S, Tomoka T, Leepan EB, Heckmann JM (2011) Silent casualties from the measles outbreak in South Africa. S Afr Med J 101:313–314, 316–317
Anlar B, Yalaz K (2011) Prognosis in subacute sclerosing panencephalitis. Dev Med Child Neurol 53:965
Anlar B, Saatçi I, Köse G, Yalaz K (1996) MRI findings in subacute sclerosing panencephalitis. Neurology 47:1278–1283
Anlar B, Yalaz K, Oktem F, Köse G (1997) Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon. Neurology 48:526–528
Anlar B, Köse G, Gürer Y, Altunbaşak S, Haspolat S, Okan M (2001a) Changing epidemiological features of subacute sclerosing panencephalitis. Infection 29:192–195
Anlar B, Söylemezoğlu F, Aysun S, Köse G, Belen D, Yalaz K (2001b) Tissue inflammatory response in subacute sclerosing panencephalitis (SSPE). J Child Neurol 16:895–900
Anlar B, Ayhan A, Hotta H, Itoh M, Engin D, Barun S, Köseoglu O (2002a) Measles virus RNA in tonsils of asymptomatic children. J Paediatr Child Health 38:424–425
Anlar B, Pinar A, Yaşar Anlar F, Engin D, Ustaçelebi S, Kocagöz T, Us D, Akduman D, Yalaz K (2002b) Viral studies in the cerebrospinal fluid in subacute sclerosing panencephalitis. J Infect 44:176–180
Anlar B, Aydin OF, Guven A, Sonmez FM, Kose G, Herguner O (2004) Retrospective evaluation of interferon-beta treatment in subacute sclerosing panencephalitis. Clin Ther 26:1890–1894
Bakir TF (1989) Viral meningitis and encephalitis in Saudi Arabia. J Trop Pediatr 35:211–213
Bellini WJ, Rota JS, Lowe LE, Katz RS, Dyken PR, Zaki SR, Shieh WJ, Rota PA (2005) Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis 192:1686–1693
Bouteille M, Fontaine C, Vedrenne C, Delarue J (1965) Sur un cas d’encbphalite subaigue a inclusions. Etude anatomoclinique et ultrastructurale. Rev Neurol 113:454
Cherian T, Joseph A, John TJ (1984) Low antibody response in infants with measles and children with subclinical measles virus infection. J Trop Med Hyg 87:27–31
Committee on Infectious Diseases; American Academy of Pediatrics (2011) Policy statement–recommended childhood and adolescent immunization schedules–United States, 2011. Pediatrics 127:387–388
Connolly JH, Haire M, Hadden DS (1971) Measles immunoglobulins in subacute sclerosing panencephalitis. Br Med J 1:23–25
Dittmar S, Harms H, Runkler N, Maisner A, Kim KS, Schneider-Schaulies J (2008) Measles virus-induced block of transendothelial migration of T lymphocytes and infection-mediated virus spread across endothelial cell barriers. J Virol 82:11273–11282
Dyken PR, Swift A, DuRant RH (1982) Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex. Ann Neurol 11:359–363
Erturk O, Karslıgil B, Cokar O, Yapıcı Z, Demirbilek V, Gurses C, Yalcinkaya C, Gokyigit A, Direskeneli GS, Yentur S, Onal E, Yılmaz G, Dervent A (2011) Challenges in diagnosing SSPE. Childs Nerv Syst 27:2041–2044
European Centre for Disease Prevention and Control (ECDC). European monthly measles monitoring (EMMO) 2011. Stockholm. http://ecdc.europa.eu/en/publications/Publications/1109_European_monthly_measles_monitoring_August_2011.pdf.
Filia A, Tavilla A, Bella A, Magurano F, Ansaldi F, Chironna M, Nicoletti L, Palù G, Iannazzo S, Declich S, Rota MC (2011). Measles in Italy, July 2009 to September 2010. Euro Surveill 16: pii: 19925.
Fukuyama Y, Nihei K, Matsumoto S, Ebina T, Kamoshita S, Sato T, Arima M, Yabuuchi H, Ueda S, Ohtahara S et al (1987) Clinical effects of MND-19 (Inosiplex) on subacute sclerosing panencephalitis–a multi-institutional collaborative study–The Inosiplex-SSPE Research Committee. Brain Dev 9:270–282
Gadoth N, Kott E, Levin S, Hahn T (1989) The interferon system in subacute sclerosing panencephalitis and its response to isoprinosine. Brain Dev 11:308–312
Gibbs FA, Gibbs EL, Spies HW, Carpenter PR (1964) Common types of childhood encephalitis: electroencephalographic and clinical relationships. Arch Neurol 10:1–11
Gunaratne PS, Rajendran T, Tilakaratne S (2001) Neurological complications of measles. Ceylon Med J 46:48–50
Gürer YK, Kükner S, Sarica B (1996) Intravenous gamma-globulin treatment in a patient with subacute sclerosing panencephalitis. Pediatr Neurol 14:72–74
Haddad FS, Risk WS (1980) Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: a controlled study. Ann Neurol 7:185–188
Hirayama T, Ikeda K, Hidaka T, Nagata R, Yoshii Y, Kawabe K, Iwasaki Y (2010) Unilateral measles-associated retrobulbar optic neuritis without encephalitis: a case report and literature review. Case Rep Neurol 2:128–132
Horta-Barbosa L, Fuccillo DA, London WT, Jabbour JT, Zeman W, Sever JL (1969) Isolation of measles virus from brain cell cultures of two patients with subacute sclerosing panencephalitis. Proc Soc Exp Biol Med 132:272–277
Jones CE, Dyken PR, Huttenlocher PR, Jabbour JT, Maxwell K (1982) Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, non-randomised study in 98 patients. Lancet 1:1034–1037
Katayama Y, Kohso K, Nishimura A, Tatsuno Y, Homma M, Hotta H (1998) Detection of measles virus mRNA from autopsied human tissues. J Clin Microbiol 36:299–301
Katz M, Rorke LB, Masland WS, Koprowski H, Tucker SH (1968) Transmission of an encephalitogenic agent from brains of patients with subacute sclerosing panencephalitis to ferrets. Preliminary report. N Engl J Med 279:793–798
Kim SJ, Kim JS, Lee DY (2003) Neurologic outcome of acute measles encephalitis according to the MRI patterns. Pediatr Neurol 28:281–284
Kühne Simmonds M, Brown DW, Jin L (2006) Measles viral load may reflect SSPE disease progression. Virol J 3:49
Laboccetta AC, Tornay AS (1964) Measles encephalitis. Report of 61 cases. Am J Dis Child 107:247–255
Lee KY, Cho WH, Kim SH, Kim HD, Kim IO (2003) Acute encephalitis associated with measles: MRI features. Neuroradiology 45:100–106
Lisse I, Samb B, Whittle H, Jensen H, Soumare M, Simondon F, Aaby P (1998) Acute and long-term changes in T-lymphocyte subsets in response to clinical and subclinical measles. A community study from rural Senegal. Scand J Infect Dis 30:17–21
Luzi P, Leoncini L, Valassina M, Federico A, Palma L (1997) Chronic progressive leptomeningitis associated with measles virus. Lancet 350:338–339
Maas S, Kawahara Y, Tamburro KM, Nishikura K (2006) A-to-I RNA Editing and Human Disease. RNA Biol 3:1–9
Meyer E, Byers RK (1952) Measles encephalitis; a follow up study of sixteen patients. AMA Am J Dis Child 84:543–579
Miki K, Komase K, Mgone CS, Kawanishi R, Iijima M, Mgone JM, Asuo PG, Alpers MP, Takasu T, Mizutani T (2002) Molecular analysis of measles virus genome derived from SSPE and acute measles patients in Papua, New Guinea. J Med Virol 68:105–112
Moss WJ, Griffin DE (2012) Measles. Lancet 2012 379:153–164
Mustafa MM, Weitman SD, Winick NJ, Bellini WJ, Timmons CF, Siegel JD (1993) Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature. Clin Infect Dis 16:654–660
Nakajima M, Sakuishi K, Fukuda S, Fujioka S, Hashida H (2008) Recovery from adult measles encephalitis immediately after early immunomodulation. Clin Infect Dis 47:148–149
Nakayama T, Mori T, Yamaguchi S, Sonoda S, Asamura S, Yamashita R, Takeuchi Y, Urano T (1995) Detection of measles virus genome directly from clinical samples by reverse transcriptase-polymerase chain reaction and genetic variability. Virus Res 35:1–16
Naniche D, Varior-Krishnan G, Cervoni F, Wild TF, Rossi B, Rabourdin-Combe C, Gerlier D (1993) Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 67:6025–6032
Öktem F, Nester MJ, Anlar B (1997) Mental assessment in subacute sclerosing panencephalitis: Hacettepe Cognitive Short Assessment Scale. J Child Neurol 12:398–402
Ölmez A, Yilmaz D, Tan H, Duman O, Güngör S, Okuyaz C, Anlar B (2007) Cerebrospinal fluid pressures in subacute sclerosing panencephalitis. Brain Dev 29:409–412
Otaki M, Jiang DP, Sasayama M, Nagano-Fujii M, Hotta H (2007) Generation of recombinant adenovirus expressing siRNA against the L mRNA of measles virus and subacute sclerosing panencephalitis virus. Microbiol Immunol 51:985–991
Paunio M, Hedman K, Davidkin I, Valle M, Heinonen OP, Leinikki P, Salmi A, Peltola H (2000) Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age. Epidemiol Infect 124:263–271
Pipo-Deveza JR, Kusuhara K, Silao CL, Lukban MB, Salonga AM, Sanchez BC, Kira R, Takemoto M, Ishizaki Y, Yukaya N, Kusuhara K, Kira R, Torisu H, Ihara K, Sakai Y, Sanefuji M, Pipo-Deveza JR, Silao CL, Sanchez BC, Lukban MB, Salonga AM, Hara T (2010) PD1 as a common candidate susceptibility gene of subacute sclerosing panencephalitis. Hum Genet 127:411–419
Piskin AK, Akpinar P, Muftuoglu S, Anlar B (2007) Signaling lymphocyte activating molecule (SLAM) expression in subacute sclerosing panencephalitis. Brain Dev 29:439–442
Plaza JA, Nuovo GJ (2005) Histologic and molecular correlates of fatal measles infection in children. Diagn Mol Pathol 14:97–102
Prasad SR, Shaikh NJ, Verma S, Banerjee K (1995) IgG & IgM antibodies against measles virus in unvaccinated infants from Pune: evidence for subclinical infections. Indian J Med Res 101:1–5
Prashanth LK, Taly AB, Sinha S, Ravi V (2007) Subacute sclerosing panencephalitis (SSPE): an insight into the diagnostic errors from a tertiary care university hospital. J Child Neurol 22:683–688
Reuter D, Schneider-Schaulies J (2010) Measles virus infection of the CNS: human disease, animal models, and approaches to therapy. Med Microbiol Immunol 199:261–271
Robertson WC Jr, Clark DB, Markesbery WR (1980) Review of 38 cases of subacute sclerosing panencephalitis: effect of amantadine on the natural course of the disease. Ann Neurol 8:422–425
Sever AE, Rainey JJ, Zell ER, Hennessey K, Uzicanin A, Castillo-Solórzano C, Dietz V (2011) Measles elimination in the Americas: a comparison between countries with a one-dose and two-dose routine vaccination schedule. J Infect Dis 204(Suppl 2):S748–755
Shu M, Liu Q, Wang J, Ao R, Yang C, Fang G, Wan C, Guo W (2011) Measles vaccine adverse events reported in the mass vaccination campaign of Sichuan province, China from 2007 to 2008. Vaccine 29:3507–3510
Srivastava SP, Nema HV (1963) Optic neuritis in measles. Brit J Ophthal 47:180–181
Stanescu A, Janta D, Lupulescu E, Necula G, Lazar M, Molnar G, Pistol A (2011) Ongoing measles outbreak in Romania, 2011. Euro Surveill 16: pii:19932.
Tatsuo H, Ono N, Tanaka K, Yanagi Y (2000) SLAM (CDw150) is a cellular receptor for measles virus. Nature 406:893–897
Thurner B, Spangenberg P, Kleines M, Blaum M, Scheithauer S, Häusler M (2007) Continuous intrathecal interferon alpha application in subacute sclerosing panencephalitis. Pediatr Infect Dis J 26:863
Tomiyasu K, Ishiyama M, Kato K, Komura M, Ohnuma E, Inamasu J, Takahashi T (2009) Bilateral retrobulbar optic neuritis, Guillain-Barré syndrome and asymptomatic central white matter lesions following adult measles infection. Intern Med 48:377–381
Tomoda A, Nomura K, Shiraishi S, Hamada A, Ohmura T, Hosoya M, Miike T, Sawaishi Y, Kimura H, Takashima H, Tohda Y, Mori K, Kato Z, Fukushima A, Nishio H, Nezu A, Nihei K (2003) Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan. Brain Dev 25:514–517
Torisu H, Hara T (2006) Analysis of MxA, IL-4, and IRF-1 genes in Filipino patients with subacute sclerosing panencephalitis. Neuropediatrics 37:222–228
Torisu H, Kusuhara K, Kira R, Bassuny WM, Sakai Y, Sanefuji M, Takemoto M, Hara T (2004) Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis. Neurology 62:457–460
Tyler HR (1957) Neurological complications of rubeola (measles). Medicine (Baltimore) 36:147–167
Valassina M, Meacci F, Valensin PE, Cusi MG (2000) Detection of neurotropic viruses circulating in Tuscany: the incisive role of Toscana virus. J Med Virol 60:86–90
Watanabe A, Yoneda M, Ikeda F, Terao-Muto Y, Sato H, Kai C (2010) CD147/EMMPRIN acts as a functional entry receptor for measles virus on epithelial cells. J Virol 84:4183–93
Yalaz K, Anlar B, Oktem F, Aysun S, Ustacelebi S, Gurcay O, Gucuyener K, Renda Y (1992) Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis. Neurology 42:488–491
Yilmaz V, Demirbilek V, Gürses C, Yentür SP, Uysal S, Yapici Z, Yilmaz G, Muncey A, Cokar O, Onal E, Gökyiğit A, Saruhan-Direskeneli G (2007) Interleukin (IL)-12, IL-2, interferon-gamma gene polymorphisms in subacute sclerosing panencephalitis patients. J Neurovirol 13:410–415
Yüksel D, Sonmez PA, Yilmaz D, Senbil N, Gurer Y (2011) Ocular findings in subacute sclerosing panencephalitis. Ocul Immunol Inflamm 19:135–138
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Basel
About this chapter
Cite this chapter
Anlar, B., Yalaz, K. (2013). Measles Virus Infection and Subacute Sclerosing Panencephalitis. In: Jackson, A. (eds) Viral Infections of the Human Nervous System. Birkhäuser Advances in Infectious Diseases. Springer, Basel. https://doi.org/10.1007/978-3-0348-0425-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-0348-0425-7_1
Published:
Publisher Name: Springer, Basel
Print ISBN: 978-3-0348-0424-0
Online ISBN: 978-3-0348-0425-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)